[Heart failure and circulatory control peptides].
Takeshita
A
A
D000804:Angiotensin II / Q000502:physiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000502:physiology*; D006333:Heart Failure / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D012084:Renin-Angiotensin System; D012964:Sodium / Q000378:metabolism; D014667:Vasopressins / Q000502:physiology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D014667:Vasopressins; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D012964:Sodium